M
Michael D. Prados
Researcher at University of California, San Francisco
Publications - 466
Citations - 57545
Michael D. Prados is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Glioma & Temozolomide. The author has an hindex of 107, co-authored 444 publications receiving 51418 citations. Previous affiliations of Michael D. Prados include Harvard University & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas
Kavita Mishra,Dev R. Puri,Brian T. Missett,Kathleen R. Lamborn,Michael D. Prados,Mitchel S. Berger,Anuradha Banerjee,Nalin Gupta,William M. Wara,Daphne A. Haas-Kogan +9 more
TL;DR: It was unable to demonstrate a benefit for administering radiation as part of initial treatment, but an outcome benefit was seen with greater extent of resection.
Journal ArticleDOI
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
Nicholas Butowski,Susan M. Chang,Kathleen R. Lamborn,Mei Yin C. Polley,Ram Parvataneni,Maria Hristova-Kazmierski,Luna Musib,Steven J. Nicol,Donald Thornton,Michael D. Prados +9 more
TL;DR: Enzastaurin 250 mg/d given concomitantly with RT and temozolomide and adjuvantly with temozoomide was well tolerated and is the recommended phase II dose.
Journal ArticleDOI
Phase I Clinical Trial of Mafosfamide in Infants and Children Aged 3 Years or Younger With Newly Diagnosed Embryonal Tumors: A Pediatric Brain Tumor Consortium Study (PBTC-001)
Susan M. Blaney,James M. Boyett,Henry S. Friedman,Amar Gajjar,Russ Geyer,Marc Horowtiz,Daniel Hunt,Mark W. Kieran,Larry E. Kun,Roger J. Packer,Peter C. Phillips,Ian F. Pollack,Michael D. Prados,Richard L. Heideman +13 more
TL;DR: The maximum tolerated dose and recommended phase II dose of IT mafosfamide in patients younger than 3 years with newly diagnosed embryonal CNS tumors is 14 mg.
Journal ArticleDOI
Intracranial myxopapillary ependymoma: case report.
Ronald E. Warnick,Jack M Raisanen,Bruce T. Adornato,Michael D. Prados,Richard L. Davis,David A. Larson,Philip H. Gutin +6 more
TL;DR: The patient, a 37-year-old woman, developed recurrent symptoms including scotomata, disorientation, and headache during two successive pregnancies before the definitive diagnosis of a myxopapillary ependymoma arising from the lateral ventricle.
Journal ArticleDOI
Intradural chordoma of the tentorium cerebelli: Case report
TL;DR: This is the first reported case of a primary intradural chordoma distant from the clivus and involving both the supra- and infratentorial compartments.